RGEN
Repligen Corp price
0% Past Week
Market Cap
8.95B
Day’s Range
52W Range
Volume (3M)
560.61K
Price-Earnings Ratio
66.44
Revenue
729.33M
Repligen Corp Latest News
Repligen Co. (NASDAQ:RGEN) Shares Sold by Cherry Creek Investment Advisors Inc.EIN News Investing3 days agoCherry Creek Investment Advisors Inc. Cuts Stock Holdings in Repligen Co. (NASDAQ:RGEN)The AM Reporter3 days ago
Sciencast Management LP Acquires Stake in Repligen Co.: A Promising Move in a Growing Biotechnology SectorBest Stocks3 days ago
About Repligen Corp
Repligen Corp is an American bioprocessing company engaged in the development, production, and commercialisation of high-value, innovative products used in the process of manufacturing biologic drugs. The firm supplies a range of customers worldwide, including life sciences companies, global biopharmaceutical firms, and contract manufacturers. The firm was founded in 1981 and is based in Boston, Massachusetts. In addition to operating manufacturing sites in Massachusetts, Repligen Corp also owns sites in California, Sweden, and Germany.
The company has contributed to various important medical advances including products for cell culture intensification, tangential flow depth filtration, pre-packed columns, single-use cassettes, and integrated tangential flow filtration (TFF) systems. Repligen Corp is a leading manufacturer of Protein A affinity ligands, which are a critical component of Protein A resins used in the manufacture of monoclonal antibody therapeutics.
The firm’s products are marketed to customers across the globe through a direct commercial organisation operating in the United States, Europe, and Asia. Repligen Corp also works with strategic partners and distributors in select markets. The firm trades on the NASDAQ, where it is publicly listed under the stock ticker RGEN.
Use your eToro watchlist to monitor the RGEN price chart and receive real-time news updates and information on Repligen Corp.
Show MoreTony J. Hunt, MBA
CEO
2K
Employees
1981
Founded
Waltham, Massachusetts, US
HQ
Upcoming Events
31
OCT
REPORTS
Repligen Corp Q3 2023 earnings report is expected to be released before market open
Get insight into a company's sustainability using ESG (environmental, social, and governance) scores.
0
100
58
High
Industry
Avg. 47
65
Environment
68
Social
46
Governance
Business Involvement Flags
GMO
Companies engaged in plant and animal breeding, genetics and genomics, including
animal and plant DNA testing services.
People Also Bought
AXTA Axalta Coating Systems 1.47% 
SSNC SS&C Technologies Holdings Inc 0.71% 
AZTA Azenta Inc -0.86% 
FCN FTI Consulting Inc -1.18% 
CENTA Central Garden & Pet Company -0.66%